The FDA does not disclose company names for BTD decisions. They provide statistics broken down by approval, rejection and withdrawn. Regardless of BTD status, IPIX has no solution to pay for phase 3 without a partnership. The hope was for great P results rallying the shares, but there's no funding to pay the CRO. Basically, IPIX is frozen like good old Absssi phase 3.... Still waiting 3 years now? LOL
Market Data 
Markets 
AI
